PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32952954-7	2020	Results: Therapeutic combination of liposomal nanovaccine and CpG with anti PD-1 mAb, demonstrated the increased number of tumor infiltrated lymphocytes (TILs) in TME with the highest IFN-gamma production and cytotoxic activity, which led to remarkable tumor regression.	nanovaccine	46-57	interferon gamma	Mus musculus	184-193	
33936096-5	2021	The nanovaccine induced robust antigen-specific Th1 (IFN-gamma, IL-2) and IL-17 cytokines plus CD4+ proliferating T-cells and memory (CD44high CD62Lhigh) and effector (CD44high CD62Llow) phenotypes in immunized mice.	nanovaccine	4-15	interferon gamma	Mus musculus	53-62	
30868883-7	2019	After immunization with a subcutaneous injection, the nanovaccine, especially MAN-OVA-IMNPs, induced more antigen-specific CD8+ T cells, greater lymphocyte activation, stronger cross-presentation, and more generation of memory T cells, antibody, IFN-gamma, and granzyme B.	nanovaccine	54-65	interferon gamma	Mus musculus	246-255	
28659922-8	2017	Immunization of HLA A2.1 transgenic mice with this peptide-based nanovaccine candidate induced peptide-specific IFNgamma-producing CD8+ T cells and conferred significant protection against L. infantum infection.	nanovaccine	65-76	interferon gamma	Mus musculus	112-120